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Mycobacterium  avium  complex  (MAC)  infection  is  a  common  opportunistic  infection  in  patients  with  AIDS  (acquired 
immune  deficiency  syndrome).  Pulmonary  involvement  of  MAC  may  range  from  asymptomatic  colonization  of  the  respiratory 
tract  to  invasive  parenchymal  or  cavitary  disease.  However,  endobronchial  lesions  with  MAC  infection  are  rare  in 
immunocompetent  and  immunosuppressed  hosts.  Here,  we  report  MAC  infection  presenting  as  an  endobronchial  mass  in 
a  patient  with  AIDS.
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INTRODUCTION
Mycobacterium  avium  complex  (MAC)  is  well-known  as  a 
common  opportunistic  organism  in  patients  infected  with  the 
human  immunodeficiency  virus  (HIV)
1).  MAC  also  acts  as  a 
pulmonary  pathogen  in  immunocompetent  patients  with 
underlying  structural  lung  diseases  such  as  chronic  obstructive 
pulmonary  disease  (COPD)  and  bronchiectasis,  as  well  as  in 
destructive  lung  lesions  like  those  observed  previously  in 
diagnosed  tuberculosis
2).  Pulmonary  involvement  of  MAC  may 
range  from  airway  colonization  to  invasive  parenchymal  disease. 
Pulmonary  parenchymal  disease  with  MAC  occurs  rarely  in 
patients  with  HIV  in  the  absence  of  dissemination
3).
Endobronchial  involvement  due  to  M.  tuberculosis  is  a  well- 
described  and  a  relatively  common  manifestation  of  tuberculosis 
in  the  Republic  of  Korea
4).  However,  endobronchial  lesions 
involved  in  MAC  infection  are  rarely  found  in  immunocompetent 
and  immunosuppressed  hosts
5, 6).  There  have  been  few  reports 
of  an  endobronchial  presentation  of  MAC  infection  in  patients 
with  acquired  immune  deficiency  syndrome  (AIDS)
6-11).  Here,  we 
report  an  MAC  infection  presenting  as  an  endobronchial  mass 
in  a  patient  with  AIDS  receiving  anti-retroviral  chemotherapy.
CASE REPORT
A  40-year-old  male  was  admitted  to  the  hospital  because  of 
cough  with  sputum  lasting  for  seven  days.  He  was  known  to  be 
HIV-positive  from  a  diagnosis  made  eight  months  previously. 
Five  months  prior  to  admission,  he  was  diagnosed  with  Pneumo-
cystis  carinii  (P.  carinii)  pneumonia  (PCP),  cytomegalovirus 
(CMV)  pneumonia,  and  herpes  zoster  infection  on  the  skin.  He 
was  then  started  on  lamivudine,  zidovudine,  and  indinavir  as 
anti-retroviral  therapy  and  trimethoprim/sulfamethoxazole  as 
PCP  prophylaxis.  At  that  time,  his  CD4  and  CD8  lymphocyte 
counts  were  356/mm
3  and  1546/mm
3,  respectively,  and  his 
CD4/CD8  ratio  was  0.23.  His  HIV  viral  load  (measured  by 
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Figure  1.  Chest  radiograph  shows  increased  haziness  at  the  left 
lower  lung  field  with  obliteration  of  the  cardiac  border;  this 
indicates  a  lobar  pneumonia  at  the  lingular  division  of  the  upper 
lobe  and  bilateral  enlargement  of  the  suprahilar  area  with  a 
prominent  left  hilum. 
Figure  3.  Bronchoscopic  examination  shows  a  polypoid  smooth- 
surfaced  mass  lesion  that  completely  occluded  the  lingular  division 
of  the  left  upper  lobe  bronchus.
 
Figure 2. Chest CT scan shows irregular bronchial narrowing with consolidation in the lingular division of the left upper lobe. Small pleural 
effusion  and  hilar  lymphadenopathy  are  also  noted. 
prior  to  admission,  the  patient  presented  with  a  cough  that 
produced  sputum  and  a  three-day  history  of  fever.
On  admission,  the  physical  examination  showed  inspiratory 
crackles  at  the  left  lower  lung  field  on  chest  auscultation.  The 
patient  was  not  febrile  or  tachypneic.  The  chest  radiograph 
demonstrated  an  increased  opacity,  with  obliteration  of  the 
cardiac  border  at  the  lower  left  lobe  of  the  lung  and  bilateral 
hilar  enlargement  (Figure  1).  In  addition,  the  computed 
tomography  (CT)  scan  of  the  chest  demonstrated  irregular 
bronchial  narrowing  and  consolidation  at  the  lingular  segment  of 
the  left  upper  lobe,  and  also  showed  bilateral  hilar  and 
subcarinal  lymphadenopathy  (Figure  2).  Bronchoscopic  examina-
tion  revealed  a  polypoid  mass-like  lesion  of  approximately  1  cm 
in  diameter  that  was  occluding  the  lingular  division  of  the  left 
upper  lobe  of  the  lung  (Figure  3). 
Biopsy  of  the  lesions  revealed  granulomatous  inflammation 
with  epitheloid  cells  without  caseation  necrosis  (Figure  4). 
Bronchial  washing  fluid  showed  small  numbers  of  acid-fast 
bacilli  (AFB)  on  Ziehl-Neelsen  staining  (Figure  4).  The  patient 
was  treated  with  isoniazid,  rifampicin,  ethambutol,  and 
pyrazinamide  following  the  diagnosis  of  endobronchial 
tuberculosis.  His  respiratory  symptoms  were  improved  and  the 
chest  radiograph  showed  a  slightly  improved  state  in  the  left 
lung  field  after  the  initiation  of  treatment.  After  two  months  of 
treatment  with  anti-tuberculosis  medication,  M.  avium  was  
Figure  4.  Microscopic  examination  shows  granulomatous  inflammation  with  non-caseation  necrosis  (H&E,  X200)  (left).  Acid-fast  stain  of 
the  bronchial  washing  fluid  demonstrates  numerous  mycobacterium  within  macrophages  (Ziehl-Neelsen  stain,  X400)  (right). 
 
Figure  5.  After  several  months  of  treatment,  the  chest  radiograph  shows  an  improved  left  lung  field  (left),  and  the  bronchoscopic 
examination  shows  mild  fibrotic  change  without  a  mass  lesion  at  the  lingular  division  of  the  upper  lobe  bronchus  (right). 
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cultured  from  his  expectorated  sputum  and  bronchial  washing 
fluid.  The  medication  was  then  changed  to  rifabutin  150  mg/day, 
ethambutol  1,200  mg/day,  and  clarithromycin  1,000  mg/day.  Two 
months  after  this  change  in  treatment,  the  patient  was 
asymptomatic  and  his  chest  radiograph  was  improved. 
Bronchoscopic  examination  showed  mild  fibrotic  changes 
without  the  presence  of  a  mass-like  lesion  at  the  lingular 
division  of  the  left  upper  lobe  (Figure  5).  At  this  time,  five 
months  after  the  initiation  of  combination  anti-retroviral  therapy, 
his  CD4  and  CD8  cell  counts  were  227/mm
3  and  828/mm
3, 
respectively,  and  his  CD4/CD8  ratio  was  0.27.  His  viral  load  was 
less  than  25  copies/mL. 
DISCUSSION
This  is  the  first  report  of  an  endobronchial  mass  caused  by 
MAC  infection  in  a  patient  with  AIDS  in  the  Republic  of  Korea. 
In  a  report  on  opportunistic  infections  of  HIV/AIDS  patients  in 
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third  most  common  opportunistic  infection,  and  was  the  most 
common  initial  infection  identified  when  patients  first  presented 
with  AIDS
12).  Atypical  mycobacterial  infection  accounted  for  only 
six  cases  (4%)  in  150  AIDS  patients,  and  the  specific  type  of 
atypical  mycobacterium  was  not  described
12).  There  has  been 
one  case  report  of  Mycobacterium  avium  complex-intracellular 
(MAI)  meningoencephalitis  in  a  patient  with  AIDS  and 
preexisting  disseminated  MAC  infection  from  the  Republic  of 
Korea
13).  There  was  a  recently  published  report  of  endobronchial 
lesions  caused  by  Mycobacterium  avium  Infection  in  an 
immunocompetent  21-year-old  patient  with  no  preexisting  lung 
disease
14). 
Although  isolated  pulmonary  involvement  with  MAC  is 
relatively  common  in  immunocompetent  hosts,  it  is  uncommon 
in  patients  with  AIDS
11).  Because  isolated  pulmonary 
involvement  with  MAC  is  rare,  and  given  the  high  frequency  of 
colonization  in  bronchial  trees,  histological  confirmation  is 
required  to  support  positive  cultures  from  respiratory 
specimens
15).  For  the  patient  reported  here,  several  sputum 
cultures  and  the  bronchial  washing  fluid  culture  showed 
mycobacterium,  specifically  MAC,  and  the  histological 
examination  showed  granulomatous  inflammation  with  epitheloid 
cells  in  the  bronchoscope  biopsy  specimen.  Because  the 
histological  examination  usually  does  not  distinguish  M. 
tuberculosis  from  MAC,  culture  for  mycobacterium  is  required  to 
confirm  MAC  infection
15).  At  first,  a  malignant  tumor  was 
suspected  because  the  lung  and  bronchoscopic  findings 
showed  a  polypoid  mass  that  completely  occluded  the  lingular 
division  of  the  left  upper  lobe  of  the  lung.  However,  the 
diagnosis  of  pulmonary  infection  with  MAC  was  confirmed  by 
repeated  sputum  culture,  bronchial  washing  fluid  culture,  and 
histological  examination.
It  has  been  suggested  that  endobronchial  disease  with  MAC 
results  from  the  restoration  of  the  immune  response  during 
anti-retroviral  therapy  (immune  reconstitution  syndrome)
8, 16, 17).  It 
has  been  hypothesized  that  patients  may  experience  a 
subclinical  infection  that  becomes  clinically  manifest  as  host 
cellular  immunity  recovers  after  the  initiation  of  anti-retroviral 
therapy.  This  suggests  that  the  host  immune  response  is  a 
cofactor  in  causing  disease.  When  MAC  infection  is  due  to  the 
immune  reconstitution  syndrome,  the  symptoms  are  expected  to 
appear  within  two  to  four  weeks  after  the  initiation  of  anti- 
retroviral  therapy. 
The  patient  reported  here  was  diagnosed  with  P.  carinii 
pneumonia  and  CMV  pneumonia  prior  to  the  diagnosis  of  MAC 
infection.  Following  diagnosis,  the  patient  was  started  on 
anti-retroviral  therapy.  After  several  months  of  anti-retroviral 
therapy,  isolated  pulmonary  infection  with  MAC  developed.  In 
this  case,  the  development  of  MAC  infection,  after  the  initiation 
of  anti-retroviral  therapy,  occurred  over  a  longer  interval  than 
that  reported  previously
16, 17).
The  clinical  features  of  isolated  pulmonary  MAC  infection  in 
patients  with  HIV  include:  fever,  cough,  and  night  sweats,  and 
are  often  accompanied  by  dyspnea,  hemoptysis,  and/or  weight 
loss.  Radiographic  patterns  have  included  mediastinal  adeno-
pathy,  patchy  bilateral  alveolar  infiltrates,  nodular  infiltrates,  and 
normal  findings  on  chest  roentgenograms.  Blood  cultures  are 
normally  negative  for  MAC
18).
  Treatment  of  isolated  pulmonary 
MAC  infection  is  usually  successful,  with  favorable  outcomes 
described  in  21  of  21  reported  cases
11, 19).
In  conclusion,  patients  with  HIV/AIDS  who  present  with 
respiratory  symptoms  and  a  chest  radiograph  with  lung  infiltrates 
and  adenopathy  during  anti-retroviral  therapy  should  be 
evaluated  for  potentially  isolated  pulmonary  MAC  infection. 
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